4B Technologies Overview
- Year Founded
-
2017
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
11
4B Technologies General Information
Description
Manufacturer of neurological disorder medicines designed to slow down or halt disease progression. The company utilises allosteric modulation and humanised monoclonal antibodies, providing pharmaceutical companies and healthcare providers with neurological disorder medicines, central nervous system therapeutics, neurodegenerative disease treatments, non-opioid pain therapies, investigational monoclonal antibodies, and transformative medicines to achieve analgesic effects without the side effects of broad nerve growth factor pathway disruptions.
Contact Information
Website
www.4btechnologies.comCorporate Office
- Room 2106, 2nd Floor, Building D, Number 33
- Number 99, Kechuang 14th Street, Beijing Economic-Technological Development Area
- Beijing, 100176
- China
Corporate Office
- Room 2106, 2nd Floor, Building D, Number 33
- Number 99, Kechuang 14th Street, Beijing Economic-Technological Development Area
- Beijing, 100176
- China
4B Technologies Timeline
4B Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 01-Feb-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 12-Dec-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A2) | 09-Feb-2021 | $25M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 01-Jan-2020 | Completed | Generating Revenue |
4B Technologies Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing Fangsheng Investment Management Center | Growth/Expansion | Minority | ||
| Beijing Zhongguancun Collaborative Innovation Investment Fund Management | Corporate Venture Capital | Minority | ||
| Daoyuan Capital | Venture Capital | Minority | ||
| Fortune Capital | Venture Capital | Minority | ||
| Zhuhai China Thrive Fund Management | Growth/Expansion | Minority |
4B Technologies FAQs
-
When was 4B Technologies founded?
4B Technologies was founded in 2017.
-
Where is 4B Technologies headquartered?
4B Technologies is headquartered in Beijing, China.
-
What industry is 4B Technologies in?
4B Technologies’s primary industry is Drug Discovery.
-
Is 4B Technologies a private or public company?
4B Technologies is a Private company.
-
What is 4B Technologies’s current revenue?
The current revenue for 4B Technologies is .
-
How much funding has 4B Technologies raised over time?
4B Technologies has raised $39.1M.
-
Who are 4B Technologies’s investors?
Beijing Fangsheng Investment Management Center, Beijing Zhongguancun Collaborative Innovation Investment Fund Management, Daoyuan Capital, Fortune Capital, and Zhuhai China Thrive Fund Management are 5 of 11 investors who have invested in 4B Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process